Internal Medicine, Endocrinology, Diabetes, & Metabolism · Los Angeles, CA
NPI
1235117128
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
8700 Beverly Blvd.
Los Angeles, CA, 90048
Phone (310) 423-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
203 services
Medicare patients, 2024
87
Average age 69
Drug cost, 2024
$646K
353 prescriptions
Company payments, 2024
$3,877
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vivien Bonert was code 99231 (hospital e&m - subsequent), 89 times for 20 patients. In total Vivien Bonert billed 203 services in 14 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99231 Hospital E&M - Subsequent | Facility | 89 | 20 | $42.18 | $3,754 |
| 99214 Office E&M - Established | Facility | 41 | 33 | $74.14 | $3,040 |
| 99213 Office E&M - Established | Facility | 15 | 13 | $49.11 | $737 |
| 99215 Office E&M - Established | Facility | 13 | 12 | $120.34 | $1,564 |
| 99222 Hospital E&M - Initial | Facility | 12 | 12 | $111.47 | $1,338 |
By year: 2022 $18K for 247 services; 2023 $17K for 202 services; 2024 $14K for 203 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vivien Bonert prescribed most often to Medicare patients was Hydrocortisone, with 66 prescriptions and refills. In total Vivien Bonert wrote 353 Medicare prescriptions that cost $646K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocortisone Generic | 66 | 89 | 12 | $1,444 |
| Levothyroxine Sodium Generic | 61 | 107 | 15 | $509 |
| Somavert Pegvisomant | 28 | 28 | Under 11 | $347K |
| Testosterone Cypionate Generic | 26 | 33 | Under 11 | $1,160 |
| Synthroid Levothyroxine Sodium | 26 | 58 | Under 11 | $2,034 |
| Desmopressin Acetate Generic | 19 | 31 | Under 11 | $952 |
| Cabergoline Generic | 19 | 34 | Under 11 | $600 |
| Testosterone Generic | 17 | 25 | Under 11 | $1,035 |
| Sandostatin Lar Depot Octreotide Acetate,mi-Spheres | 14 | 14 | Under 11 | $83K |
| Norditropin Flexpro Somatropin | 13 | 13 | Under 11 | $12K |
| Mycapssa Octreotide Acetate | 12 | 12 | Under 11 | $79K |
| Genotropin Somatropin | 12 | 12 | Under 11 | $20K |
Brand drugs: 171 claims; generic drugs: 182 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Vivien Bonert $3,877 ($3,877 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $3,877.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 7 | $3,877 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.